Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CORTEVA, INC.

(CTVA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Corteva : Barclays Adjusts Price Target on Corteva to $51 From $53, Maintains Equal-Weight Rating

08/09/2021 | 10:09am EDT


ę MT Newswires 2021
All news about CORTEVA, INC.
10/13WALL STREET STOCK EXCHANGE : Earnings season is off to a good start
10/13ANALYST RECOMMENDATIONS : AstraZeneca, BT Group, Constellation Brands, EasyJet, Skyworks....
10/13CORTEVA : Mizuho Securities Starts Corteva at Buy With $53 Price Target
MT
10/12CORTEVA : 10th Annual Global Food Security Index Shows Overall Decline in Food Security
PR
10/08CORTEVA : Roth Capital Starts Corteva at Buy with $53 Price Target
MT
10/08BAYER : Corteva faces slow start as it takes aim at Bayer's Brazil soy reign
RE
09/20CORTEVA : Agriscience Announces Winners for 2021 Climate Positive Leaders Program
PR
09/08CORTEVA : Agreement with Gaïago to Develop and Distribute Biofungicide Solutions
PU
09/07CORTEVA : Three conversation starters to use at the farmers market
PU
09/01CORTEVA : Berenberg Starts Corteva at Buy With $58 Price Target
MT
More news
Analyst Recommendations on CORTEVA, INC.
More recommendations
Financials (USD)
Sales 2021 15 297 M - -
Net income 2021 1 265 M - -
Net cash 2021 2 148 M - -
P/E ratio 2021 25,0x
Yield 2021 1,28%
Capitalization 31 944 M 31 944 M -
EV / Sales 2021 1,95x
EV / Sales 2022 1,83x
Nbr of Employees 21 000
Free-Float 99,9%
Chart CORTEVA, INC.
Duration : Period :
Corteva, Inc. Technical Analysis Chart | CTVA | US22052L1044 | MarketScreener
Technical analysis trends CORTEVA, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Last Close Price 43,51 $
Average target price 50,85 $
Spread / Average Target 16,9%
EPS Revisions
Managers and Directors
James C. Collins Chief Executive Officer & Director
David John Anderson Chief Financial Officer & Executive Vice President
Gregory R. Page Non-Executive Chairman
Debra King Chief Information Officer & Senior Vice President
Sam Eathington Chief Technology Officer & Senior Vice President
Sector and Competitors